ARMISTICE CAPITAL, LLC - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 20 filers reported holding INMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$450,000
-49.6%
956,118
+87.5%
0.01%
-46.7%
Q3 2021$893,000
-68.4%
510,000
-42.7%
0.02%
-70.6%
Q2 2021$2,830,000
+264.7%
890,000
+278.7%
0.05%
+183.3%
Q1 2021$776,000235,0000.02%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 61,741$58,0000.27%
AllSquare Wealth Management LLC 545$1,0000.00%
TWO SIGMA SECURITIES, LLC 17,979$17,0000.00%
Creative Planning 10,832$10,0000.00%
ROYAL BANK OF CANADA 250$00.00%
TCI Wealth Advisors, Inc. 125$00.00%
TWO SIGMA INVESTMENTS, LP 39,700$37,0000.00%
OSAIC HOLDINGS, INC. 1,185$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,905$13,0000.00%
View complete list of INMED PHARMACEUTICALS INC shareholders